Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resection

Published 2012 View Full Article

Authors

Keywords

Journal

SURGERY

Volume 153, Issue 4, Pages 565-575

Publisher

Elsevier BV

Online

2012-12-17

DOI

10.1016/j.surg.2012.10.010

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

SURGERY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Become a Peeref-certified reviewer